Pharming (PHAR) Inventory Average (2020 - 2025)

Pharming's Inventory Average history spans 6 years, with the latest figure at $60.3 million for Q4 2025.

  • Quarterly results put Inventory Average at $60.3 million for Q4 2025, up 134.46% from a year ago — trailing twelve months through Dec 2025 was $60.3 million (up 134.46% YoY), and the annual figure for FY2025 was $60.3 million, up 134.46%.
  • Inventory Average for Q4 2025 was $60.3 million at Pharming, up from $25.7 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $60.3 million in Q4 2025 to a low of -$3.1 million in Q4 2023.
  • The 5-year median for Inventory Average is $9.0 million (2021), against an average of $18.0 million.
  • The sharpest move saw Inventory Average crashed 124.42% in 2022, then surged 923.56% in 2024.
  • Year by year, Inventory Average stood at $9.0 million in 2021, then crashed by 124.42% to -$2.2 million in 2022, then crashed by 41.37% to -$3.1 million in 2023, then surged by 923.56% to $25.7 million in 2024, then skyrocketed by 134.46% to $60.3 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $60.3 million, $25.7 million, and -$3.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.